On December 2004, American Biomed, Inc. went out of business as per its Chapter 7 liquidation filing under bankruptcy. With facilities in California and Texas and formerly traded as ABMI, the firm (OTC:ABMIQ) had designed and mades medical devices for use in interventional cardiology, endovascular surgery, and minimally invasive surgery. The company's primary products included atherectomy catheters which removed plaque from blood vessels or implanted devices, blood clot filters, stents, silicone balloon catheters which removed arterial blockage or gallstones; measure cardiac output; and angioscopically view blood vessels, and drug-delivery catheters.
